Organon & Co. advanced stock charts by Barron's. View OGN historical stock data and compare to other stocks, and exchanges.

BofA analyst Jason Gerberry lowered the firm’s price target on Organon (OGN) to $10 from $11 and keeps an Underperform rating ...

A humorous look at the companies that caught our eye, for better or worse, this week ...

Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what ...

Shares of Organon & Co. fell to a record low on Thursday after a series of analyst downgrades and price target cuts followed ...

Evercore ISI analyst Umer Raffat downgraded Organon (OGN) to In Line from Outperform following its “surprising” dividend cut. The company’s top ...

The DJS Law Group announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") for violations of the securities laws. INVESTIGATION DETAILS: The ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for ...

Organon & Co's quarterly results showed a noticeable drop in EPS, which was lower than both the previous year's figure and the upper end of analyst projections. The company's revenue also experienced ...

Pharmaceutical company Organon (NYSE:OGN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell ...

The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its ...

Organon (OGN) stock dropped 13% after the company's Q1 results indicated its plans to cut dividends to $0.02/share amid a ...